阿哌沙班与依诺肝素在根治性膀胱切除术后预防静脉血栓栓塞的比较：CARE 试验。

IF 4.8 2区医学 Q1 UROLOGY & NEPHROLOGY

European urology focus Pub Date : 2024-10-22 DOI:10.1016/j.euf.2024.10.002

Katharine F Michel, Michelle Slinger, Hanna Stambakio, Ruchika Talwar, Amy N Luckenbough, Max Kates, Sunil H Patel, Luke J Keele, Trinity J Bivalacqua

引用次数: 0

摘要

CARE 是一项务实的随机临床试验，旨在比较阿哌沙班和依诺肝素在根治性膀胱切除术后出院时作为 VTE 预防用药的依从性、满意度、患者自付费用和静脉血栓栓塞（VTE）发生率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Comparison of Apixaban Versus Enoxaparin for Venous Thromboembolism Prevention After Radical Cystectomy: The CARE Trial.

CARE is a pragmatic randomized clinical trial designed to compare adherence, satisfaction, patient out-of-pocket costs, and venous thromboembolism (VTE) rates between apixaban and enoxaparin prescribed as VTE prophylaxis on discharge after radical cystectomy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European urology focus Medicine-Urology

CiteScore

10.40

自引率

3.70%

发文量

274

审稿时长

23 days

期刊介绍： European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.